Where does Melinta Subsidiary Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Melinta Subsidiary Corp. ranks #20,069 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Melinta Subsidiary Corp. hold?

Melinta Subsidiary Corp. holds 14 US utility patents granted between 2019 and 2024, spanning 9 technology areas.

What is Melinta Subsidiary Corp.'s Innovation Score?

Melinta Subsidiary Corp. has an Innovation Score of 48.6 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Melinta Subsidiary Corp. focus on?

Melinta Subsidiary Corp.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 11 patents, ranking #1,740 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Melinta Subsidiary Corp.'s patent grant rate increasing or decreasing?

Melinta Subsidiary Corp.'s recent grant velocity is +500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Melinta Subsidiary Corp.'s patents?

Melinta Subsidiary Corp.'s patents average 20.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Melinta Subsidiary Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Melinta Subsidiary Corp.

USPTO PatentsView assignee record - 14 granted patents across 9 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Melinta ranks #20,069 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 9 technology areas.

#20,069
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.6/100): 20.0
avg claims per patent: +500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20069 · US Corporation #20,069 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,069/49,997
PHOTO-FINISH Maxton Engineering
CPC-NARROW A61P · 9 areas
INNOV-PAR 48.6/100
CLAIMS-DENSE 20.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Maxton Engineering Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Melinta’s 48.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (19%) Velocity 16.7 pts (34%) Breadth 10.6 pts (22%) Claim depth 12.0 pts (25%)

Qualcomm Incorporated · highest

85
Melinta Subsidiary · this assignee

49
3D Lighting… · lowest

7

What this shows Melinta's Innovation Score is 48.6/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Melinta?

Each dot is one of Melinta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Melinta’s own 20.0 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Melinta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Melinta's grants concentrate

Melinta Subsidiary Corp. is a focused PatentsView assignee: 9 CPC subclasses with 78.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2023. By volume, Melinta sits between Maxton Engineering Ltd. and Midatech Ltd..

Melinta's three-year grant acceleration

Melinta Subsidiary Corp. shows 10 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Maxton Engineering

14
Mayeaux Holding

14
Mccloskey Interna…

14
Mean Well (Guangz…

14
Merge Healthcare…

14
Micro-star Int'l

14
Microtec S R L

14
Midatech

14
Melinta Subsidiary ◀

14

What this shows Melinta holds 14 patents at rank #20,048, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Melinta

By rank, the assignees closest to #20,048 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Melinta's primary technology class.

Melinta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Melinta Subsidiary Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	14.3%
2021	2	14.3%
2022	3	21.4%
2023	1	7.1%
2024	6	42.9%

Which technologies does Melinta Subsidiary Corp. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 11

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 5

Y02A - Technologies FOR Adaptation TO Climate Change 5

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C07C - Acyclic OR Carbocyclic Compounds 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Melinta Subsidiary Corp.'s patent record in context - here's where to go next.

Melinta Subsidiary Corp.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 78.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #20,069 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Melinta Subsidiary Corp. against Maxton Engineering Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.